Venture fund to be extended by two years

Market conditions have prompted the Health Care & Biotechnology Venture Fund to be extended two years until February 28/04. The closed-end investment trust managed by MDS Capital Corp will divest all of its assets by that date at the latest. The fund has already paid in excess of its paid-in capital to unit holders and its remaining net asset value as of May 18/01 was $31.1 million.